ethinyl estradiol has been researched along with Hyperlipoproteinemia Type III in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dairou, F; De Gennes, JL; Epelboin, S; Tuffert, J | 1 |
| Falko, JM; Kolar, J; Schonfeld, G; Weidman, SW; Witztum, JL | 1 |
| Cornish, EJ; Hain, R; Nash, AL | 1 |
| Demacker, PN; Stuyt, PM; van't Laar, A | 1 |
4 other study(ies) available for ethinyl estradiol and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
[Normalization of lipid levels in an 87-year-old woman with a type III dysbetalipoproteinemia by ethinyl estradiol (author's transl)].
Topics: Aged; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemia Type III; Lipids; Lipoproteins | 1980 |
Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
Topics: Apolipoproteins; Cholesterol; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1979 |
Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Topics: Adolescent; Adult; Antithrombin III; Ascorbic Acid; Ceruloplasmin; Cholesterol; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Norgestrel; Phospholipids; Triglycerides | 1979 |
A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, VLDL; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1986 |